Solid phase synthesis of indinavir and its analogues

被引：17

作者：

Cheng, Y ^{[1
]}

Lu, ZJ ^{[1
]}

Chapman, KT ^{[1
]}

Tata, JR ^{[1
]}

机构：

[1] Merck Res Labs, Basic Chem Dept, Combinatorial Chem Grp, Rahway, NJ 07065 USA

来源：

JOURNAL OF COMBINATORIAL CHEMISTRY | 2000年 / 2卷 / 05期

关键词：

D O I：

10.1021/cc000029z

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

[No abstract available]

引用

页码：445 / 446

页数：2

共 11 条

[1]

ASKIN D, 1998, DRUG DISCOVERY DEV, V1, P338

[2] Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitors [J].

Baker, CT ;

Salituro, FG ;

Court, JJ ;

Deininger, DD ;

Kim, EE ;

Li, BQ ;

Novak, PM ;

Rao, BG ;

Pazhanisamy, S ;

Schairer, WC ;

Tung, RD .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (24) :3631-3636

[3] HIV-1 protease inhibitors - A review for clinicians [J].

Deeks, SG ;

Smith, M ;

Holodniy, M ;

Kahn, JO .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (02) :145-153

[4] L-735,524 - THE DESIGN OF A POTENT AND ORALLY BIOAVAILABLE HIV PROTEASE INHIBITOR [J].

DORSEY, BD ;

LEVIN, RB ;

MCDANIEL, SL ;

VACCA, JP ;

GUARE, JP ;

DARKE, PL ;

ZUGAY, JA ;

EMINI, EA ;

SCHLEIF, WA ;

QUINTERO, JC ;

LIN, JH ;

CHEN, IW ;

HOLLOWAY, MK ;

FITZGERALD, PMD ;

AXEL, MG ;

OSTOVIC, D ;

ANDERSON, PS ;

HUFF, JR .

JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (21) :3443-3451

[5]

Kempf DJ, 1996, CURR PHARM DESIGN, V2, P225

[6] EXPEDIENT METHOD FOR THE SOLID-PHASE SYNTHESIS OF ASPARTIC-ACID PROTEASE INHIBITORS DIRECTED TOWARD THE GENERATION OF LIBRARIES [J].

KICK, EK ;

ELLMAN, JA .

JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (09) :1427-1430

[7] Cyclic imidate salts in acyclic stereochemistry: Diastereoselective syn-epoxidation of 2-alkyl-4-enamides to epoxyamides [J].

Maligres, PE ;

Weissman, SA ;

Upadhyay, V ;

Cianciosi, SJ ;

Reamer, RA ;

Purick, RM ;

Sager, J ;

Rossen, K ;

Eng, KK ;

Askin, D ;

Volante, RP ;

Reider, PJ .

TETRAHEDRON, 1996, 52 (09) :3327-3338

[8] Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials - Compensatory modulations of binding and activity [J].

Schock, HB ;

Garsky, VM ;

Kuo, LC .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (50) :31957-31963

[9] L-735,524 - AN ORALLY BIOAVAILABLE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR [J].

VACCA, JP ;

DORSEY, BD ;

SCHLEIF, WA ;

LEVIN, RB ;

MCDANIEL, SL ;

DARKE, PL ;

ZUGAY, J ;

QUINTERO, JC ;

BLAHY, OM ;

ROTH, E ;

SARDANA, VV ;

SCHLABACH, AJ ;

GRAHAM, PI ;

CONDRA, JH ;

GOTLIB, L ;

HOLLOWAY, MK ;

LIN, J ;

CHEN, IW ;

VASTAG, K ;

OSTOVIC, D ;

ANDERSON, PS ;

EMINI, EA ;

HUFF, JR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4096-4100

[10] Clinically effective HIV-1 protease inhibitors [J].

Vacca, JP ;

Condra, JH .

DRUG DISCOVERY TODAY, 1997, 2 (07) :261-272

← 1 2 →